Cohu stock fell 6.86% after reporting Q4 results with revenue of $122.2 million (up 30% YoY, meeting expectations) but posting an unexpected adjusted loss of $0.15 per share versus analyst expectations of $0.06 profit. The company projects Q1 revenue roughly in line with Q4 and expects gross margins to improve to ~45%, with HBM product sales anticipated between $15-20 million for the full year.

Semiconductor equipment provider Cohu reported Q2 2025 results exceeding Wall Street expectations, with revenue of $107.7 million and positive non-GAAP earnings. The company saw growth primarily in the mobile segment, secured a $28 million design-win order, and continues to focus on strategic acquisitions and cost management.

The global power electronics testing market is expected to grow at a CAGR of 10.2% from 2024 to 2029, driven by the surge in electric vehicle adoption and the need for reliable power electronics in various industries.

Citi downgraded Cohu Inc's stock from Buy to Neutral, citing challenges in the semiconductor market and the need for visible recovery signs in Cohu's key end markets such as automotive, mobile, and industrial sectors.

Analysts' ratings for Cohu (NASDAQ:COHU) over the last quarter vary from bullish to bearish, as provided by 4 analysts. The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 3 0 1 0 0 Last 30D 1 0 0 0 0 1M Ago 1 0 1 0 0 2M Ago 0 0 0 0 0 3M Ago 1 0 0 0 0 Insights from analysts' 12-month price targets are revealed, presenting an average target of $35.0, a high estimate of $40.00, and a low estimate of $30.00. This current average represents a 9.49% decrease from the previous average price target of $38.67. Exploring Analyst Ratings: An In-Depth Overview A comprehensive examination of how financial experts perceive Cohu is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets. Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target Charles Shi Needham Lowers Buy $34.00 $36.00 Craig Ellis B. Riley Securities Lowers Buy $40.00 $45.00 Christian Schwab Craig-Hallum Lowers Hold $30.00 $35.00 Charles Shi Needham Maintains Buy $36.00 - Key Insights: Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Cohu. This information provides a snapshot of how ...Full story available on Benzinga.com

Cohu (COHU) delivered earnings and revenue surprises of 200% and 0.57%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

Cohu might see a continued drop in revenue during 2024, but it's gearing up for a substantial growth cycle.

Veeco (VECO) delivered earnings and revenue surprises of 18.60% and 2.31%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?

Cohu (COHU) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

This stock isn't as glamorous as some of its peers in the chip sector, but it can still deliver upside for investors.

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Keybanc cut Skyworks Solutions Inc (NASDAQ: SWKS) price target from $130 to $120. Keybanc analyst John Vinh maintained an Overweight rating. Skyworks shares fell 4.3% to $85.70 in pre-market trading. See how other analysts view this stock. Needham lowered the price target for Cohu, Inc. (NASDAQ: COHU) from $52 to $42. Needham analyst Quinn Bolton maintained a Buy rating. Cohu shares fell 2.1% to $30.60 in pre-market trading. See how other analysts view this stock. HC Wainwright & Co. raised Outlook Therapeutics Inc (NASDAQ: OTLK) price target from $1 to $2. HC Wainwright & Co. analyst Douglas Tsao maintained a Buy ...

An updated screen highlights chip makers expected to show high-double-digit growth rates, along with some surprisingly low stock valuations.